The page or information you have requested is intended for an audience outside the United States. By continuing to browse you confirm that you are a non-US resident requesting access to this page or information.

This website uses cookies. By continuing to use this website you consent to using cookies. For more information about cookies and how we use them, please see our Privacy Policy.

SCAI 2015 San Diego

This program highlights the role of percutaneous mechanical circulatory support (MCS) for patients with severe cardiovascular compromise.

The use of percutaneous mechanical circulatory support (MCS) has been rapidly evolving as devices become smaller, more efficient, easier to deploy and less invasive. The purpose of this session is to share an expert’s experience on the use of counterpulsation therapy in the treatment of a patient at high-risk for cardiovascular compromise during percutaneous coronary intervention (PCI) considering current evidence, risk of complication and cost.


Manish A. Parikh, MD, FACC
Associate Professor of Clinical Medicine
Director, Physician Education
New York-Presbyterian Hospital/Columbia University Medical Center


Joseph L. Thomas, MD FSCAI
Assistant Health Sciences Professor
David Geffen UCLA School of Medicine
Director, Interventional Cardiology
Harbor-UCLA Medical Center

Atman Shah, MD
Associate Professor of Medicine
Co-Director, Cardiac Catherization Lab
Clinical Director Section of Cardiology
University of Chicago

Learning objectives

  • To understand the science of mechanical circulatory support in the complex coronary patient
  • To systematically determine which device to use for patient’s specific needs
  • To discuss real-world experience and outcomes in treating complex PCI procedures